Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.

Informe acción SZSE:301096

Capitalización de mercado: CN¥4.3b

Hangzhou Bio-Sincerity Pharma-TechLtd Crecimiento futuro

Future controles de criterios 5/6

Hangzhou Bio-Sincerity Pharma-TechLtd is forecast to grow earnings and revenue by 37.6% and 29.9% per annum respectively. EPS is expected to grow by 37.5% per annum. Return on equity is forecast to be 15% in 3 years.

Información clave

37.6%

Tasa de crecimiento de los beneficios

37.5%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Life Sciences34.7%
Tasa de crecimiento de los ingresos29.9%
Rentabilidad financiera futura15.0%
Cobertura de analistas

Low

Última actualización16 Aug 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Sep 30
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SZSE:301096) Soars 30% But It's A Story Of Risk Vs Reward

Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower

Jul 24
Market Cool On Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.'s (SZSE:301096) Earnings Pushing Shares 27% Lower

Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Apr 29
Solid Earnings May Not Tell The Whole Story For Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096)

Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

Mar 14
Should You Be Adding Hangzhou Bio-Sincerity Pharma-TechLtd (SZSE:301096) To Your Watchlist Today?

Previsiones de crecimiento de beneficios e ingresos

SZSE:301096 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20262,134598-1207134
12/31/20251,687463-2695024
12/31/20241,315357-1354884
9/30/20241,025212-693-126N/A
6/30/20241,119287-647-5N/A
3/31/20241,072287-751-28N/A
12/31/20231,017272-59890N/A
9/30/2023900250-520135N/A
6/30/2023786229-531154N/A
3/31/2023673210-388289N/A
1/1/2023607194-332259N/A
9/30/2022573192-319241N/A
6/30/2022479155-194224N/A
3/31/2022425126-178117N/A
12/31/2021374111-103145N/A
9/30/2021304101-167100N/A
6/30/202126785-20480N/A
3/31/202121155-22949N/A
12/31/202020757-20154N/A
12/31/201915644-3571N/A
12/31/201882112645N/A
12/31/201726-7N/A11N/A
6/30/2017308N/A11N/A
3/31/2017275N/A6N/A
12/31/2016243N/A2N/A
9/30/2016211N/A1N/A
6/30/201616-1N/A5N/A
3/31/2016162N/A4N/A
1/1/2016165N/A3N/A
12/31/20146-2N/A1N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: 301096's forecast earnings growth (37.6% per year) is above the savings rate (2.9%).

Beneficios vs. Mercado: 301096's earnings (37.6% per year) are forecast to grow faster than the CN market (25.8% per year).

Beneficios de alto crecimiento: 301096's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: 301096's revenue (29.9% per year) is forecast to grow faster than the CN market (14% per year).

Ingresos de alto crecimiento: 301096's revenue (29.9% per year) is forecast to grow faster than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: 301096's Return on Equity is forecast to be low in 3 years time (15%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y